Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NOTA-exendin-4 PET/CT for Insulinoma and Nesidioblastosis
NCT02560376Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Feb 2014
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Peking Union Medical College Hospital. Primary endpoint: Standardized Uptake Value at 1 year. Status: unknown.
Beyond the preview
Go deeper on NCT02560376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02560376.